Agilent Technologies Inc (A) - Medical Equipment - Deals and Alliances Profile

Date: April 24, 2018
Pages: 101
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AD7A301FDA8EN
Leaflet:

Download PDF Leaflet

Agilent Technologies Inc (A) - Medical Equipment - Deals and Alliances Profile
Summary

Agilent Technologies Inc (Agilent) is a provider of instruments, reagents, software, services and consumables for comprehensive laboratory workflow. Its product portfolio comprises atomic absorption systems, bioanalyzers, gene expression microarrays and automation systems, among others. The company serves biotechnology, pharmaceutical, contract research organizations (CROs) and contract manufacturing organizations (CMOs), chemical and energy, environmental and forensics, and food industries. Agilent markets its products through direct sales force, distributors, manufacturers’ representatives, resellers and e-commerce. It has research and development (R&D) and manufacturing facilities in the US, the UK, Denmark, Germany, Italy, Japan, Malaysia, China, Singapore and Australia. Agilent is headquartered in Santa Clara, California, the US.

Agilent Technologies Inc (A) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.

NOTE: Out of security concerns GlobalData requires using corporate email address.
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deal Details
Asset Purchase
Agilent Technologies to Reacquire Assets of Varian
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies
Dako To Acquire Intellectual Property Rights From System Dynamics
Venture Financing
NanoCellect Biomedical Raises USD10 Million in Series B Financing
Private Equity
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital
Partnerships
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool
Agilent Technologies Enters into Agreement with University of Southern California
Agilent Technologies and Agendia Enter into Agreement
Luxcel Biosciences and HD Biosciences Enter into Agreement
Agilent Technologies Enters into Agreement with Burning Rock Biotech
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging
Agilent Technologies Enters into Agreement with Eurofins Genomics
Agilent Technologies Enters into Agreement with 10X Genomics
Protea Biosciences Enters into Agreement with Agilent Technologies
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific
Merck and Pfizer Enters into Agreement with Dako
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic
Dako Enters into Development Agreement with ONO PHARMA for Opdivo
Agilent Extends Co-Marketing Agreement with MRM Proteomics
Dako Enters into Agreement with Merck for Companion Diagnostic Test
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay
Agilent Enters Into Research Agreement With Chungnam National University
Agilent Technologies Enters Into Co-Development Agreement With Florida International University
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics
Dako Enters Into Agreement With Pfizer For Companion Diagnostics
Agilent Technologies Enters Into Research Agreement With Ameritox
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests
Advion Enters Into Technology Integration Agreement With Agilent Technologies
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers
Dako Enters Into Co-Development Agreement With Amgen
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics
Dako Enters Into Co-Development Agreement With Amgen
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology
Eppendorf Enters Into Licensing Agreement With Agilent Technologies
Debt Offering
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million
Asset Transactions
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
Acquisition
Agilent Technologies to Acquire Remaining 52% Stake in Lasergen for USD105 Million
Agilent Technologies to Acquire Advanced Analytical Technologies for USD250 Million
Agilent Technologies Acquires Luxcel Biosciences
Agilent Technologies Acquires Multiplicom for USD72 Million
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million
Agilent Technologies Acquires Cartagenia for USD68.34 Million
Agilent Technologies To Acquire ABC Instrumentacion Analitica
Leica Biosystems Completes Acquisition Of Aperio Technologies
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion
Agilent Technologies Inc - Key Competitors
Agilent Technologies Inc - Key Employees
Agilent Technologies Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Apr 04, 2018: Agilent and BioTek Join Forces to Create an Integrated Metabolic Analysis and Imaging Platform
Jul 07, 2017: Agilent Technologies Opens New Customer & Technology Center in Waldbronn, Germany
Financial Announcements
Feb 14, 2018: Agilent Technologies Reports First-Quarter Fiscal Year 2018 Financial Results
Nov 20, 2017: Agilent Technologies Reports Fourth-Quarter Fiscal Year 2017 Financial Results
Aug 15, 2017: Agilent Technologies Reports Third-Quarter Fiscal Year 2017 Financial Results
May 22, 2017: Agilent Technologies Reports Second-Quarter Fiscal Year 2017 Financial Results
Feb 14, 2017: Agilent Technologies Reports First-Quarter 2017 Results
Corporate Communications
Apr 16, 2018: Agilent Announces Departure of Patrick Kaltenbach
Jan 18, 2018: Agilent Technologies Appoints Dow R. Wilson As Board Director
Jan 18, 2018: Dow R. Wilson to Join Agilent's Board of Directors
Jul 18, 2017: Hans E. Bishop to Join Agilent's Board of Directors
May 04, 2017: Agilent Technologies Receives Multiple Awards at Scientific Conference in China
Mar 20, 2017: Agilent Technologies Hires Samraat 'Sam' Raha to Head Strategy and Corporate Development
Mar 15, 2017: Agilent Technologies Board of Directors Elects Koh Boon Hwee as New Chairman
Mar 14, 2017: Agilent Technologies Receives 2017 Scientists’ Choice Award for Best Webinar Series
Feb 21, 2017: Agilent Technologies Receives Dow's Western Canada Science and Technical Excellence Conference Awards (WesTEC) for Technical Excellence and Innovation
Legal and Regulatory
Jan 11, 2017: Applied Spectral Imaging announced that its GenASIs applications comply with CE-IVD requirements with the IQFISH lung cancer panel on Dako Omnis of Agilent Technologies
Product News
Apr 09, 2018: Agilent Highlights Lab Efficiency through Innovative Solutions at Analytica 2018
Mar 15, 2018: Agilent Introduces New Color for Cancer Diagnosis
Jun 19, 2017: Agilent Technologies Unveils New Analytical and Purification Solutions at HPLC 2017
Jun 05, 2017: Prosolia DESI 2D Molecular Imaging Now Compatible with Agilent Technologies
Other Significant Developments
Feb 28, 2018: Agilent and Imperial College London Announce Collaboration Agreement
Feb 08, 2018: Agilent to Support Korea Doping Control Center
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Agilent Technologies Inc, Medical Equipment, Key Facts, 2017
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment Deals By Type, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Agilent Technologies Inc, Deals By Market, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018
Agilent Technologies to Reacquire Assets of Varian
Agilent Technologies Acquires Next Generation Sequencing IP Portfolio from Population Genetics Technologies
Dako To Acquire Intellectual Property Rights From System Dynamics
NanoCellect Biomedical Raises USD10 Million in Series B Financing
Agilent Technologies Recommends Stockholders to Reject Mini-Tender Offer of TRC Capital
Agilent Technologies Enters Into Licensing Agreement With SRI International For BioCyc Pathway Database Collection
Dako Enters Into Licensing Agreement With Van Andel Research Institute For Cancer Diagnostic Tool
Agilent Technologies Enters into Agreement with University of Southern California
Agilent Technologies and Agendia Enter into Agreement
Luxcel Biosciences and HD Biosciences Enter into Agreement
Agilent Technologies Enters into Agreement with Burning Rock Biotech
Agilent Technologies Enters into Co-Marketing Agreement with Applied Spectral Imaging
Agilent Technologies Enters into Agreement with Eurofins Genomics
Agilent Technologies Enters into Agreement with 10X Genomics
Protea Biosciences Enters into Agreement with Agilent Technologies
Agilent Technologies Enters into Agreement with Thermo Fisher Scientific
Merck and Pfizer Enters into Agreement with Dako
Dako Enters into Co-Development Agreement with Amgen for Companion Diagnostic
Dako Enters into Development Agreement with ONO PHARMA for Opdivo
Agilent Extends Co-Marketing Agreement with MRM Proteomics
Dako Enters into Agreement with Merck for Companion Diagnostic Test
Agilent Technologies Enters Into Agreement With Cell Line Genetics For Regenerative Medicine
Dako Enters Into Co-Development Agreement With Amgen For Molecular Diagnostic Test
Dako And Omnyx Enter Into Co-Marketing Agreement For Breast Cancer Diagnostics
Agilent Technologies Enters Into Agreement With SomaLogic For SOMAscan Proteomic Assay
Agilent Enters Into Research Agreement With Chungnam National University
Agilent Technologies Enters Into Co-Development Agreement With Florida International University
Agilent Technologies Enters Into Co-Development Agreement With Sera Prognostics
Dako Enters Into Agreement With Pfizer For Companion Diagnostics
Agilent Technologies Enters Into Research Agreement With Ameritox
Dako Enters Into Agreement With Eli Lilly To Develop Companion Diagnostic Tests
Advion Enters Into Technology Integration Agreement With Agilent Technologies
Agilent Technologies Enters Into Co-Marketing Agreement With Molecular Discovery
Agilent Technologies Enters Into Co-Marketing Agreement With MRM Proteomics
Agilent Enters Into Co-Development Agreement With Gachon University For Biomarkers
Dako Enters Into Co-Development Agreement With Amgen
Agilent Technologies Enters Into Co-Development Agreement With Integrated Diagnostics
Dako Enters Into Co-Development Agreement With Amgen
Population Genetics Enters Into Licensing Agreement With Agilent Technologies For VeriTag Technology
Eppendorf Enters Into Licensing Agreement With Agilent Technologies
Agilent Technologies Raises USD300 Million in Public Offering of Notes Due 2026
Agilent Technologies Completes Public Offering Of Notes Due 2023 For US$600 Million
Agilent Technologies Completes Public Offering Of Notes Due 2022 For US$400 Million
BioReliance To Acquire Rights To Big Blue Colonies and Cell Lines From Agilent Technologies
Agilent Technologies to Acquire Remaining 52% Stake in Lasergen for USD105 Million
Agilent Technologies to Acquire Advanced Analytical Technologies for USD250 Million
Agilent Technologies Acquires Luxcel Biosciences
Agilent Technologies Acquires Multiplicom for USD72 Million
Agilent Technologies Acquires 48% Stake in Lasergen for USD80 Million
Agilent Technologies Acquires Seahorse Bioscience for USD242 Million
Agilent Technologies Acquires Cartagenia for USD68.34 Million
Agilent Technologies To Acquire ABC Instrumentacion Analitica
Leica Biosystems Completes Acquisition Of Aperio Technologies
Agilent Technologies Completes Acquisition Of Dako From EQT For US$2.2 Billion
Agilent Technologies Inc, Key Competitors
Agilent Technologies Inc, Key Employees
Agilent Technologies Inc, Subsidiaries

LIST OF FIGURES

Agilent Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018
Agilent Technologies Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018
Skip to top


Ask Your Question

Agilent Technologies Inc (A) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: